Sánchez-Sanz, A., Sánchez-Sanz, A., García-Martín, S., Sabín-Muñoz, J., Moreno-Torres, I., Elvira, V., . . . Sánchez-López, A. J. (2023). Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients. Frontiers Media S.A.
Chicago Style (17th ed.) CitationSánchez-Sanz, Alicia, et al. Dimethyl Fumarate-related Immune and Transcriptional Signature Is Associated with Clinical Response in Multiple Sclerosis-treated Patients. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationSánchez-Sanz, Alicia, et al. Dimethyl Fumarate-related Immune and Transcriptional Signature Is Associated with Clinical Response in Multiple Sclerosis-treated Patients. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.